Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
02/1999
02/03/1999EP0894501A1 Rheumatoid arthritis remedy containing anti-il-8 antibody as active ingredient
02/03/1999EP0894269A1 Tfiib transcription factor from candida albicans
02/03/1999EP0894144A2 Diagnosing trinucleotide repeat diseases and genes involved therein
02/03/1999EP0894141A1 Hybrid proteins which form heterodimers
02/03/1999EP0894140A1 Allele suppression
02/03/1999EP0894139A1 Sensitization of her-2/neu overexpressing cancer cells to chemotherapy
02/03/1999EP0894137A1 Novel human myeloid terminal differentiation response gene
02/03/1999EP0894136A1 Method of treating muscular disorders
02/03/1999EP0894135A1 Multivalent and multispecific antigen-binding protein
02/03/1999EP0894134A1 Exodus chemokine materials and methods
02/03/1999EP0894133A2 Neuropeptide y receptor y5 and nucleic acid sequence
02/03/1999EP0894132A2 Adam proteins and uses thereof
02/03/1999EP0894131A1 Human hyaluronan receptor
02/03/1999EP0894130A1 Modulators of tnf receptor associated factor (traf), their preparation and use
02/03/1999EP0894129A1 Short external guide sequences
02/03/1999EP0894094A1 Process for extraction of a growth factor complex
02/03/1999EP0894093A2 Soluble tachykinin antagonists, the preparation and use thereof
02/03/1999EP0894092A1 A cyclic hepta-peptide derivative from colonial ascidians, lissoclinum sp.
02/03/1999EP0894006A1 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE THREONYL tRNA SYNTHETASE FAMILY
02/03/1999EP0894004A1 Methods for enhancing functional recovery following central nervous system ischemia or trauma
02/03/1999EP0894003A1 N-formyl hydroxylamine containing compounds useful as ace inhibitors and/or nep inhibitors
02/03/1999EP0894002A1 Novel peptides which inhibit complement activation
02/03/1999EP0893991A1 Stimulation of immune response with low doses of interleukin-2
02/03/1999EP0893968A1 Poly(amino acid) adhesive tissue grafts
02/03/1999EP0705275B1 Asp-b28 insulin crystals
02/03/1999EP0510186B1 Therapeutic uses of melanin
02/03/1999CN1207132A Psudomonas exotoxin-myelin basic protein chimeric proteins
02/03/1999CN1207131A Recombinant fusion proteins to growth hormone and serum albumin
02/03/1999CN1207126A Ligand polypeptides for the G-protein-coupled receptor protein, their production and use
02/03/1999CN1207047A Cartilage/bone inducing materials for reparation
02/03/1999CN1207046A Type IX collagen and chimeras
02/03/1999CN1207045A Nisin in combination with glycerol monolaurate active against helicobacter
02/03/1999CN1207044A Cyclosporin-containing soft capsule preparations
02/03/1999CN1207043A Inhibitors of cyclophilin rotamase activity
02/03/1999CN1207042A A Pharmaceutical composition for the treatment of autommune diseases
02/03/1999CN1206715A Amino-acid derivant and preparation process thereof, and medicinal composition containing same
02/03/1999CN1041919C N-(3-piperidinylcarbonyl)-beta-alanine derivatives as PAF antagonists
02/02/1999USRE36080 Therapy sickle cell anemia
02/02/1999US5866699 Oligonucleotides with anti-MDR-1 gene activity
02/02/1999US5866697 The dna is useful for probes to detect the dna in the herpesvirus, for expression to produce the glycoproteins can be used for producing the antibodies which specifically recognize the three glycoprotein antigens.
02/02/1999US5866696 Combination of vector and promoter can be used to introduce and express a human gene and correct a genetic defect in human cells resulting from malfunction of the mutant endogenous gene.
02/02/1999US5866694 Peptides that induce antibodies which neutralize genetically divergent HIV-1 isolates
02/02/1999US5866693 Detecting mutations in the polynucleotides encoding the madr3 or madr4 and for detecting altered levels of the polypeptide in a host.
02/02/1999US5866692 Process for producing humanized chimera antibody
02/02/1999US5866690 Human anti-malignin antibody
02/02/1999US5866689 Monoclonal antibodies to GP130 protein
02/02/1999US5866686 Nuclear thyroid hormone receptor-interacting polypeptides and related molecules and methods
02/02/1999US5866685 Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
02/02/1999US5866684 Peptidyl inhibitors of viral proteases
02/02/1999US5866682 Short peptides about 14-17 residues in length, which are naturally available in minute amounts in the venom of the cone snails.
02/02/1999US5866681 Oligopeptides
02/02/1999US5866679 Peptides
02/02/1999US5866604 Thiol derivatives with metallopeptidase inhibitory activity
02/02/1999US5866584 Administration of a dopamine agonist, over a limited period at a time of day dependent on the normal circadian rhythm of insulin resistant and insulin sensitive members of a similar species.
02/02/1999US5866570 Treatment of vascular leakage and related syndrome such as septic shock by administration of metalloproteinase inhibitors
02/02/1999US5866551 Therapy for atherosclerosis
02/02/1999US5866550 Method of inhibiting replication of hyperproliferative cells using a nucleic acid encoding EIA
02/02/1999US5866547 Methods of neuroendocrine regulation of affective disorders
02/02/1999US5866546 Administering immunoregulator and cell proliferative agent
02/02/1999US5866545 Antiinflammatory agents; nervous system disorders; gastrointestinal disorders; urogenital disorders
02/02/1999US5866543 Dna expression system
02/02/1999US5866542 Nematode-extracted anticoagulant protein
02/02/1999US5866541 Genetic engineering
02/02/1999US5866540 Cyclic adhesion inhibitors
02/02/1999US5866539 Method for the control of antibiotic-resistant gram positive bacteria and treatment of infection
02/02/1999US5866538 Stability; mixture with glycerol and(or) mannitol
02/02/1999US5866537 Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids
02/02/1999US5866536 Compounds and compositions for delivering active agents
02/02/1999US5866535 Forming antibodies
02/02/1999US5866418 Filtration; ion exchanging; ulcers, gastrointestinal disorders
02/02/1999US5866412 Chromosome 18 marker
02/02/1999US5866403 Homologously recombinant slow growing mycobacteria and uses therefor
02/02/1999US5866402 Chimeric MCP and DAF proteins with cell surface localizing domain
02/02/1999US5866390 Leucyl tRNA synthetase polynucleotides of streptococcus
02/02/1999US5866384 Cell ablation using trans-splicing ribozymes
02/02/1999US5866373 Polynucleotide encoding a human chemotactic protein
02/02/1999US5866370 Polynucleotides and polypeptides of the m29 aminopeptidase family, hereinafter referred to as ?aminopeptidase.?
02/02/1999US5866369 Amps
02/02/1999US5866367 Gidb
02/02/1999US5866366 gidB
02/02/1999US5866365 Utilizing rnc polypeptides to screen for antibacterial compounds.
02/02/1999US5866364 Recombinant bone morphogenetic protein heterodimers
02/02/1999US5866363 Method and means for sorting and identifying biological information
02/02/1999US5866360 Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
02/02/1999US5866351 CD4+ T-lymphocyte proteases and genes encoding said proteases
02/02/1999US5866332 Diagnosis and treatment of disease states related to proliferation, specifically myeloproliferative diseases and leukemias.
02/02/1999US5866329 Method and probe for detection of gene associated with liver neoplastic disease
02/02/1999US5866327 Association of kinensin with sensitivity to chemotherapeutic drugs
02/02/1999US5866325 Hybrids; detection, quantitative analysis
02/02/1999US5866323 Cancer diagnosis prognosis and therapy based on mutation of receptors for transforming growth factor β and homologous growth controlling factors
02/02/1999US5866319 Dna probe capacble of hybridizing with genome
02/02/1999US5866159 Pharmaceutical compositions comprising cyclosporins
02/02/1999US5866136 Recombinant vaccine
02/02/1999US5866134 Administering polysaccharide antibody and interleukins
02/02/1999US5866131 Recombinant vaccine
02/02/1999US5866130 Mycobacterial proteins, microorganisms producing them and their use for vaccines and for the detection of tuberculosis
02/02/1999US5866129 Method of producing an antibody with a peptide corresponding to membrane-bound IgA
02/02/1999US5866127 Vascular permeability factor targeted compounds
02/02/1999US5866126 Complexing
02/02/1999US5866125 Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof